Cargando…
A diverse portfolio of novel drug discovery efforts for Alzheimer's disease: Meeting report from the 11th International Conference on Alzheimer's Drug Discovery, 27-28 September 2010, Jersey City, NJ, USA
While Alzheimer's disease researchers continue to debate the underlying cause(s) of the disease, most agree that a diverse, multi-target approach to treatment will be necessary. To this end, the Alzheimer's Drug Discovery Foundation (ADDF) recently hosted the 11th International Conference...
Autores principales: | Lee, Linda H, Shineman, Diana W, Fillit, Howard M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3031879/ https://www.ncbi.nlm.nih.gov/pubmed/21159211 http://dx.doi.org/10.1186/alzrt57 |
Ejemplares similares
-
Beyond amyloid: a diverse portfolio of novel drug discovery programs for Alzheimer's disease and related dementias
por: Lane, Rachel F, et al.
Publicado: (2011) -
Diverse therapeutic targets and biomarkers for Alzheimer's disease and related dementias: report on the Alzheimer's Drug Discovery Foundation 2012 International Conference on Alzheimer's Drug Discovery
por: Lane, Rachel F, et al.
Publicado: (2013) -
Meeting report on the Alzheimer’s Drug Discovery Foundation 14th International Conference on Alzheimer’s Drug Discovery
por: Friedman, Lauren G, et al.
Publicado: (2014) -
Meeting the unique challenges of drug discovery for neurodegenerative diseases
por: Shineman, Diana W, et al.
Publicado: (2009) -
Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studies
por: Shineman, Diana W, et al.
Publicado: (2011)